U-500 Regular Insulin: Clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients

OBJECTIVE: To describe the clinical experience and the pharmacokinetics of U-500 regular insulin in severely insulin-resistant obese type 2 diabetic patients. RESEARCH DESIGN AND METHODS: Patients requiring >200 units of insulin with A1C levels >8.0% were switched to U-500 regular insulin. For...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidson, Mayer B., Navar, Maria D., Echeverry, Diana, Duran, Petra
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809265/
https://www.ncbi.nlm.nih.gov/pubmed/19910500
http://dx.doi.org/10.2337/dc09-1490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809265/
https://www.ncbi.nlm.nih.gov/pubmed/19910500
http://dx.doi.org/10.2337/dc09-1490

Ejemplares similares